LTF and Alzheimer disease: The combination of Aβ1-42 (reflecting amyloid accumulation) and Lf (indicating immune dysregulation) provides a multidimensional strategy for early risk prediction, post-onset diagnosis, and longitudinal monitoring of AD progression.